Blood markers may foretell kidney trouble in lupus

NCT ID NCT07780045

Not yet recruiting Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study looks at whether two blood-based inflammation markers, called SII and SIRI, can help track disease activity and predict kidney flares in people with lupus nephritis, a type of kidney inflammation caused by lupus. Researchers will follow 100 adults with confirmed lupus nephritis, measuring these markers and comparing them with standard measures of disease activity and kidney function. The goal is to see if these simple, inexpensive tests could serve as early warning signs for kidney problems, helping doctors intervene sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If these blood markers prove reliable, they could offer a simple way to monitor lupus nephritis and predict kidney flares, potentially improving early treatment decisions.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The markers may not be specific enough, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

kidney disorder lupus nephritis systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIDNEY DISEASES LUPUS NEPHRITIS SYSTEMIC LUPUS ERYTHEMATOSUS

More trials for these conditions

Other studies related to the condition(s) this trial covers.